Workflow
健康保险
icon
Search documents
5月15日电,联合健康跌超16%,跌至2020年4月以来的最低水平。
news flash· 2025-05-15 13:40
智通财经5月15日电,联合健康跌超16%,跌至2020年4月以来的最低水平。 ...
涉医疗保险欺诈 美司法部对联合健康集团展开刑事调查
news flash· 2025-05-15 02:58
金十数据5月15日讯,当地时间5月14日,美国司法部正在对美国联合健康集团展开刑事调查,案件可能 涉及医疗保险欺诈。美国司法部和联合健康集团均尚未就此次调查发表声明。此次调查正值该集团试图 从股市暴跌中恢复之际,此前其财务表现不佳,且集团首席执行官安德鲁·威蒂突然辞职,职位被董事 会主席斯蒂芬·赫姆斯利接任。就在几个月前,该集团旗下联合健康保险公司首席执行官汤普森在纽约 街头被路易吉·曼吉奥内枪杀。 涉医疗保险欺诈 美司法部对联合健康集团展开刑事调查 ...
5月15日电,美国司法部据悉正在调查联合健康可能存在的刑事欺诈行为。
news flash· 2025-05-14 23:09
智通财经5月15日电,联合健康盘后下跌4.5%。美国司法部据悉正在调查联合健康可能存在的刑事欺诈 行为。 ...
芯片股,大爆发!
Zhong Guo Ji Jin Bao· 2025-05-14 00:35
【导读】美股涨跌不一,芯片股大爆发,英伟达大涨!一巨头突然暴跌近18% 中国基金报记者 伊万 美东时间5月13日,美股三大指数涨跌不一,道指下跌,但科技股力撑纳指走高,标普500指数已收复年 内跌幅。 美股三大指数涨跌不一 特朗普政府撤销拜登任内AI芯片限制规定,芯片股大爆发!英伟达大涨近6%,已连续两日收涨超5%。 美国健康保险巨头突然暴跌近18%! 美东时间5月13日,美股市场三大指数涨跌不一,在科技股、芯片股的带领下,纳指、标普收涨,以大 型传统经济公司为主的道指则收跌。 截至收盘,道指跌0.64%,报42140.43点;标普500指数涨0.72%,报5886.55点;纳指涨1.61%,报 19010.08点。纳指、标普500指数已收复年内跌幅。 消息面上,美国总统特朗普表示,国会即将通过历史上最大规模的减税法案。税收减免法案在国会"进 展顺利",将成为推动美国经济飞跃的火箭。将向对美国征收关税的国家加征关税。股市将会大幅上 涨。药品和制药行业的价格将会降至前所未见的水平。 宏观方面,美国4月通胀数据好于预期。美国4月未季调CPI同比升2.3%,为2021年2月以来新低,预期 升2.4%,前值升2.4% ...
美股前瞻 | 三大股指期货齐跌 美国4月CPI今晚揭晓
智通财经网· 2025-05-13 11:43
3. 截至发稿,WTI原油涨0.97%,报62.55美元/桶。布伦特原油涨0.82%,报65.49美元/桶。 | ඝ 伦敦布伦特原油 | 2025年7月 | 65.49 | 65.51 | 64.62 | +0.53 | +0.82% | | --- | --- | --- | --- | --- | --- | --- | | ■ WTI原油 | 2025年6月 | 62.55 | 62.56 | 61.65 | +0.60 | +0.97% | 市场消息 关税冲击初现端倪,美国4月CPI预期反弹。美国4月CPI将于今晚公布。市场预测共识显示,美国4月CPI预计环比上涨0.3%, 同比上涨2.4%。剔除食品和能源价格的核心通胀预计上涨0.3%,同比上涨2.8%。此前在三月,由于能源价格走低推动通胀回 落,CPI出现自2020年以来的首次月度下降。多数预测人士表示,美国劳工统计局周二发布的报告将显示上月对中国和其他国 家加征的惩罚性关税的初步影响,但影响可能有限,因为上月美国货架上的许多进口商品是在新关税生效前运抵美国的。美国 银行经济学家指出:"由于关税以及相关消费者行为的影响,核心商品通胀可能加速。"美国 ...
Humana(HUM) - 2025 Q1 - Earnings Call Transcript
2025-04-30 12:00
Financial Data and Key Metrics Changes - The company reaffirmed its full-year guidance, indicating a strong start to 2025 with Q1 results ahead of plan [5][14] - Adjusted EPS guidance for the year is approximately $16.25, with an expected insurance segment benefit ratio of 90.1% to 90.5% [15][14] - G&A costs for the quarter were slightly better than expectations, attributed to the timing of costs expected in the second and third quarters [11][14] Business Line Data and Key Metrics Changes - The Medicare product and experience maintained membership guidance for 2025, with strong performance in the Open Enrollment Period (OEP) [8] - CenterWell and Medicaid businesses showed robust patient and membership growth, with 30 new centers added through acquisition and partnership [12][14] - The company reported a 30% to 50% reduction year over year in members with weight refills due to medication adherence campaigns [11] Market Data and Key Metrics Changes - The company is seeing strong year-to-date performance in markets with high concentrations of members, particularly in Florida, Illinois, and Texas [41] - Medicaid membership growth is on track, with approximately 100,000 growth year-to-date, aligning with the expected annual growth of 175,000 to 250,000 [74] Company Strategy and Development Direction - The company is focused on operational efficiencies, increasing flexibility, and operating leverage while making investments to improve member outcomes [14] - The integration between the insurance segment and CenterWell is aimed at delivering better health outcomes and improving STARS performance [58][60] - The company is committed to returning to a 3% pre-tax margin in Medicare Advantage (MA) by 2027, with ongoing focus on quality and operational excellence [48][90] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying progress of the business despite external challenges, emphasizing control over medical costs and operational efficiencies [50][52] - The company is monitoring changes in consumer behavior due to the Inflation Reduction Act (IRA) and is prepared for potential impacts on future performance [6][14] - Management highlighted the importance of navigating regulatory headwinds while focusing on controllable factors [51][52] Other Important Information - The company is actively working through STARS strategy and bids, with a focus on balancing membership and margins [32][33] - Recent fulfillment agreements with multiple companies are expected to contribute positively to growth [12][63] Q&A Session Summary Question: How much of your investments moved out of Q1? - Management indicated that most of the impact of incremental investments flowed through the MLR in Q1, with expectations for higher levels in the second through fourth quarters [20] Question: Update on the path to the 3% MA margin target? - Management reiterated focus on achieving the 3% margin, with timing tied to STARS outcomes, and no significant changes from previous communications [23] Question: Update on STARS initiatives and bids? - Management expressed confidence in progress made on STARS initiatives and ongoing work on bids, emphasizing a balanced approach to membership and margins [27][32] Question: Experience in Part D relative to expectations? - Trends in the business are consistent with expectations, with mid-single-digit growth on the medical side and low double-digit growth on the pharmacy side [36] Question: Visibility on risk adjustment and Group MA? - Management reported strong membership changes and visibility into risk adjustment, with no significant behavioral changes noted in Group MA [41][43] Question: Comments on Medicaid visibility and utilization? - Medicaid is performing in line with expectations, with strong growth and positive trends in member engagement and outcomes [75][76] Question: Clarification on GAAP EPS and valuation adjustments? - Management clarified that the adjustment in GAAP EPS guidance is unrelated to structural impairment and is part of a complex calculation [93]
Stay Ahead of the Game With Humana (HUM) Q1 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-04-28 14:22
Core Insights - Humana (HUM) is expected to report quarterly earnings of $9.98 per share, reflecting a 38% increase year over year, with revenues projected at $32.22 billion, a 9.8% increase from the previous year [1] - The consensus EPS estimate has been revised upward by 3.4% over the past 30 days, indicating analysts' positive reassessment of the company's performance [1][2] Revenue Estimates - Analysts estimate 'Revenues- Premiums' to be $30.68 billion, representing an 8.6% year-over-year increase [4] - 'Revenues- Services' are projected to reach $1.20 billion, indicating a 12.8% increase year over year [4] - 'Revenues- Investment income (loss)' is expected to be $275.11 million, reflecting a 4.5% decrease year over year [4] - 'Revenue- Insurance' is forecasted to be $31.15 billion, showing an 8.5% increase from the year-ago quarter [5] Membership Metrics - 'Medical Membership - Medicare stand-alone PDP' is expected to reach 2.45 million, up from 2.35 million in the same quarter last year [6] - 'Medical Membership- State-based contracts and other' is projected at 1.5 million, compared to 1.26 million in the previous year [6] - 'Medical Membership - Group Medicare Advantage' is estimated at 557.22 thousand, slightly up from 551.5 thousand year over year [7] - 'Medical Membership - Medicare Supplement' is forecasted at 375.88 thousand, an increase from 323.2 thousand in the previous year [7] - 'Medical Membership - Individual Medicare Advantage' is expected to be 5.2 million, down from 5.55 million year over year [7] - Total 'Medical Membership - Medicare' is projected to reach 8.21 million, down from 8.45 million in the previous year [8] - 'Medical Membership - Military services' is expected to be 5.32 million, down from 5.96 million in the same quarter last year [8] Stock Performance - Humana shares have shown a return of -0.1% over the past month, compared to a -4.3% change in the Zacks S&P 500 composite [9] - The company holds a Zacks Rank 3 (Hold), indicating expected performance in line with the overall market [9]
Elevance Health(ELV) - 2025 Q1 - Earnings Call Transcript
2025-04-22 12:30
Elevance Health, Inc. (ELV) Q1 2025 Earnings Conference Call April 22, 2025 08:30 AM ET Company Participants Conference Operator - OperatorNathan Rich - Vice President of Investor RelationsGail Boudreau - President and CEOMark Kay - Chief Financial OfficerPete Haitayan - President, CarillonFelicia Norwood - President, Government Health Benefits BusinessModerator - Call Moderator Conference Call Participants AJ Rice - Analyst, UBSLance Wilkes - Analyst, BernsteinStephen Baxter - Analyst, Wells FargoAndrew Mo ...
轻松健康集团冲刺港交所:已将轻松筹等业务剔除,2024年前三季度营收6.4亿元
IPO早知道· 2025-01-29 01:47
转型为以保险业务为核心。 微信公众号|ipozaozhidao 据IPO早知道消息,轻松健康集团于2025年1月28日正式向港交所递交招股说明书,拟主板挂牌上 市,中金公司和招商证券国际担任联席保荐人。 值得注意的是, 轻松 健康集团 已于2 024 年6月将线上疾病筹款业务(即"轻松筹")和 朵尔医院 完成剔除,即不属于本次上市主体。 成立于2014年的轻松健康集团现专注于提供综合健康服务及健康保险解决方案,致力于通过一套易 用、精准且可负担的健康解决方案,利用自身为促进中国健康服务和相关资金资源的有效配置而构建 的全方位的生态系统,为有需要的人提供保障和支持。 具体来讲:轻松健康集团的健康服务涵盖早筛、健康检查和咨询、医疗预约服务以及保健品销售。同 时,轻松健康集团还通过自己的互联网保险平台「轻松保险」,为用户提供方便地获取各种健康保险 产品的机会。截至2024年9月30日,轻松保险已提供来自36家保险公司合作伙伴的合共252款保险 产品。 截至2024年9月30日,轻松健康集团的注册用户数量为1.68亿名。2022年、2023年以及2024年 前三季度,轻松健康集团的活跃用户数量分别约为7050万名、6 ...